AI Oncology: Why big pharma sees a remedy in data and AI

Cancer medicine is on the roll! The following quote is disturbing on many counts: He cites Rozlytrek, a treatment for metastatic non-small cell lung cancer approved by the FDA in August, which targets genetic mutations seen in only about 1 per cent of all patients with the condition. The rarity made it difficult to find […]